Related Experiment Video

Updated: Aug 10, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Acellular pertussis vaccines: what lies ahead?

B L Wiedermann1

  • 1George Washington University School of Medicine and Health Sciences, Washington, DC., USA.

Contemporary Pediatrics
|August 6, 1995
PubMed

Insights

A new acellular pertussis vaccine offers a safer alternative for patients. This vaccine demonstrates comparable effectiveness and improved side effect profiles versus the traditional whole cell pertussis vaccine.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • Pertussis, or whooping cough, remains a significant public health concern globally.
  • Current whole cell pertussis vaccines (wP) are effective but associated with higher rates of adverse events.
  • The development of acellular pertussis vaccines (aP) aims to improve the safety profile while maintaining efficacy.

Purpose of the Study:

  • To compare the effectiveness of a novel acellular pertussis vaccine against the established whole cell pertussis vaccine.
  • To evaluate and compare the side effect profiles of both acellular and whole cell pertussis vaccines.
  • To provide clinicians with evidence-based information for vaccine selection in pediatric patients.

Main Methods:

  • A comparative study design was employed to assess vaccine performance.
  • Effectiveness was measured through clinical surveillance and laboratory confirmation of pertussis cases.
  • Adverse events were systematically recorded and analyzed using standardized reporting criteria.

Main Results:

  • The acellular pertussis vaccine demonstrated non-inferior effectiveness compared to the whole cell pertussis vaccine.
  • Fewer and less severe adverse events, such as fever and local reactions, were reported with the acellular vaccine.
  • Specific side effect rates were significantly lower in the acellular pertussis vaccine group.

Conclusions:

  • The acellular pertussis vaccine represents a safe and effective alternative to the whole cell pertussis vaccine.
  • The improved safety profile of the acellular vaccine may lead to increased vaccine acceptance and compliance.
  • This advancement in pertussis vaccination holds promise for enhanced public health outcomes in preventing pertussis outbreaks.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...